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Research
A key event in human population history is the 
dispersal of early humans from Africa to other 
parts of the world with different climates, 
pathogens, sources of food and xeno  biotic 
exposure, and the dynamic adaptation to the 
evolving environments (Jin and Su 2000). 
Current phenotypic differences between indi-
viduals/groups could be due partly to func-
tional polymorphisms that facilitated survival 
in the ancestral populations (Di Rienzo and 
Hudson 2005). Resolving the under  lying 
allelic architectures of environ  mental response 
and searching for their molecular adaptation 
to selective forces have been attractive indirect 
strategies for implementation and interpre-
tation of genetic analysis of environmental 
response and complex disorders (Bamshad 
and Wooding 2003; Sabeti et al. 2007).
Members of the cytochrome P450 
(CYP) 3A family are among the most impor-
tant CYP enzymes in humans. They metabolize 
various endogenous and exogenous chemicals, 
such as clinically important drugs, environmen-
tal carcinogens, cholesterol, steroids, and other 
lipids (Wojnowski 2004). Members of the 
CYP3A family are expressed in organs primarily 
associated with xeno  biotic and hormone dispo-
sition, such as the liver and gastro  intestinal tract 
(Wojnowski 2004). Four functional CYP3A 
enzymes—CYP3A4, CYP3A5, CYP3A7, and 
CYP3A43—have been identified in humans. 
CYP3A4 is most abundant in adult liver and 
intestine and is the major enzyme involved in 
xeno  biotic and drug metabolism (Fujita 2004). 
CYP3A5 is the predominant form in the kidney 
(Givens et al. 2003). CYP3A7, a feto  placental 
enzyme found only in humans, is expressed 
mainly in fetal liver (Leeder et al. 2005) and 
extra  hepatic tissues such as endometrium 
and placenta (Burk et al. 2002; Schuetz et al. 
1993). The more recently cloned CYP3A43 is 
expressed predominantly in prostate and tes-
tis (Gellner et al. 2001). Inter  individual varia-
tion in CYP3A activity up to 10-fold has been 
observed (Dorne et al. 2003). Because CYP3A 
activity is a major determinant of drug response 
and may be associated with risk for cancers 
such as breast and prostate cancer (Keshava 
et al. 2004), the identification of sequence 
variants at the CYP3A locus and functional 
characterization of their clinical relevance have 
been of long-standing interest in pharmaco-
genetics and toxico  genetics.
The human CYP3A gene cluster resides 
in a 231-kb region on chromosome 7q22 
and consists of four genes and two pseudo-
genes, arranged in the order of CYP3A5, 
CYP3A5P1, CYP3A7, CYP3A5P2, CYP3A4, 
and CYP3A43, from centromere to telo  mere 
(Finta and Zaphiropoulos 2000) (Figure 1). 
CYP3A43 is in the opposite orientation from 
all other CYP3A genes. Each intact gene 
encodes a protein consisting of 503 amino 
acids. Finta and Zaphiropoulos (2000) sug-
gested that the locus arose through duplication 
of an ancestral CYP3A cassette of 40–50 kb. 
Many genetic variants have been identified in 
this locus and are available online (http://www.
imm.ki.se/CYPalleles/); some functional vari-
ants for CYP3A have been reported, such as 
the CYP3A5*3, which results in an incorrectly 
spliced mRNA and a truncated nonfunctional 
protein (Kuehl et al. 2001).
Parallel to exploring phenotypic effects 
and clinical relevance of CYP3A genetic poly-
morphisms, investigating molecular adap-
tations to the environment is an intriguing 
complementary strategy for pharmaco  genetic 
and toxico  genetic studies. The CYP3A4 and 
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Ba c k g r o u n d: The human CYP3A gene cluster codes for cytochrome P450 (CYP) sub  family 
enzymes that catalyze the metabolism of various exogenous and endogenous chemicals and is an obvi-
ous candidate for evolutionary and environmental genomic study. Functional variants in the CYP3A 
locus may have undergone a selective sweep in response to various environmental conditions. 
oB j e c t i v e: The goal of this study was to profile the allelic structure across the human CYP3A locus 
and investigate natural selection on that locus.
Me t h o d s : From the CYP3A locus spanning 231 kb, we resequenced 54 genomic DNA fragments 
(a total of 43,675 bases) spanning four genes (CYP3A4, CYP3A5, CYP3A7, and CYP3A43) and two 
pseudogenes (CYP3AP1 and CYP3AP2), and randomly selected intergenic regions at the CYP3A 
locus in Africans (24 individuals), Caucasians (24 individuals), and Chinese (29 individuals). We 
comprehensively investigated the nucleotide diversity and haplotype structure and examined the 
possible role of natural selection in shaping the sequence variation throughout the gene cluster.
re s u l t s: Neutrality tests with Tajima’s D, Fu and Li’s D* and F*, and Fay and Wu’s H indicated 
possible roles of positive selection on the entire CYP3A locus in non-Africans. Sliding-window 
analy  ses of nucleotide diversity and frequency spectrum, as well as haplotype diversity and phylo-
genetically inferred haplotype structure, revealed that CYP3A4 and CYP3A7 had recently under-
gone or were undergoing a selective sweep in all three populations, whereas CYP3A43 and CYP3A5 
were undergoing a selective sweep in non-Africans and Caucasians, respectively. 
co n c l u s i o n: The refined allelic architecture and selection spectrum for the human CYP3A locus 
highlight that evolutionary dynamics of molecular adaptation may underlie the phenotypic varia-
tion of the xenobiotic disposition system and varied predisposition to complex disorders in which 
xenobiotics play a role.
key w o r d s : CYP3A, environmental genomics, genetic polymorphism, positive selection. Environ 
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CYP3A5 genes have a strong haplo  type struc-
ture at varying frequencies across ethnic groups 
(Thompson et al. 2004). Using a comparative 
genomics approach and sequence-based neu-
trality test, Thompson et al. (2004) reported 
evidence of positive selection on the derived 
allele of the functional CYP3A5*3 in non- 
African populations and significant correlation 
of its allelic frequency with distance from the 
equator. In a genotype-based investigation on 
the CYP3A locus, Schirmer et al. (2006) pro-
posed that negative natural selection acted pri-
marily toward the elimination in non-African 
populations of the ancestral CYP3A4*1B allele 
rather than toward the reduction of CYP3A5 
expression described by Thompson et al. 
(2004). It should be noted that these popu-
lation genetics studies were based on a small 
fraction of sequence information or on only 
limited data of genotypes of single-nucleotide 
polymorphisms (SNPs), and both had limited 
coverage of the 230-kb genomic sequence of 
CYP3A locus. Therefore, the refined molecular 
targets of natural selection on the complete 
CYP3A locus and its evolutionary dynamics 
with respect to geographically and temporally 
fluctuating environments in our demographic 
history have not yet been explicitly pinpointed.
To further identify genetic variations in 
the human CYP3A locus and assess the effect 
of natural selection on the pattern of nucleo-
tide diversity at this locus, we resequenced the 
human CYP3A locus in three populations and 
addressed evolutionary population genetics on 
the gene cluster.
Materials and Methods
Subjects and samples. We obtained human 
genomic DNA samples from two sources: 
a) we extracted genomic DNA samples from 
venous blood for 29 unrelated healthy Chinese 
men (average age, 20 ± 2 years) who were cho-
sen from the sample collection constructed 
for the Chinese Human Genome Diversity 
Project through a coordinated effort of several 
institutes (Chu et al. 1998); and b) we used 
DNA samples of 24 Caucasians (11 females, 
13 males), 24 Africans (9 females, 15 males), 
and three apes [i.e., one common chimpanzee 
(Pan troglodytes), one lowland gorilla (Gorilla 
gorilla), and one orangutan (Pongo pygmaeus)] 
provided by Coriel Cell Repositories (Camden, 
NJ, USA). Written informed consent was 
obtained from all the Chinese subjects. This 
study was performed with the approval of 
the Ethical Committee of Chinese National 
Human Genome Center at Beijing.
Sequencing strategy. A schematic repre-
sentation of genes and pseudogenes at the 
CYP3A locus and the resequenced regions is 
shown in Figure 1. We screened 54 genomic 
DNA fragments totaling 43,675 bases. The 
resequenced regions included nearly all exons 
(except exon 11 of CYP3A7 because of dif-
ficulty in sequencing the highly homologous 
sequences) and relevant exon–intron bound-
aries of four genes (CYP3A43, CYP3A4, 
CYP3A7, and CYP3A5) and two pseudo  genes 
(CYP3AP1 and CYP3AP2) and approximately 
2.5-kb promoter regions of the four intact 
genes. We also resequenced four randomly 
selected segments equally distributed across 
the CYP3A43–CYP3A4 gene interval and a 
fragment in CYP3AP2–CYP3A7 interval, with 
an average length of 1.1 kb. 
Identification of polymorphisms and 
divergences. We identified polymorphisms by 
sequencing polymerase chain reaction (PCR) 
products from both ends. Long-range PCR 
(L-PCR) amplifications were performed first 
with primers specific for the target DNA 
regions to increase specificity [GenBank acces-
sion no. NG_000004.2 (National Center for 
Biotechnology Information 2009)]. DNA 
sequencing was performed using overlapping 
primers that covered the overall L-PCR frag-
ments. We confirmed positions and individual 
genotypes of the variations by resequencing 
from the opposite strand or from overlapped 
sequencing. Fixed differences or divergences 
between humans and apes were inferred by 
aligning the resequenced sequences of humans 
with those of the three apes; we considered 
the alleles that occurred in the apes to be the 
ancestral alleles for polymorphic sites. Details 
regarding PCR and sequencing conditions, as 
well as PCR primers, are available on request. 
As a meas  ure of quality control, sequence seg-
ments of individuals presenting singletons or 
ambiguous polymorphisms were reamplified 
and resequenced. We assessed SNP data valid-
ity by repeating 10% of the assays. The error 
rate was relatively low (1.2%).
Data analysis. We performed tests of fitness 
to the Hardy-Weinberg equilibrium for each 
polymorphic site using LDA software (Ding 
et al. 2003). We used the false discovery rate 
method to correct for multiple testing using 
Q-VALUE in R (Dabney and Storey 2002) 
as described by Storey and Tibshirani (2003). 
Three meas  ures of nucleotide diversity were 
assessed: average nucleotide diversity (π), a sta-
tistic based on the average number of pairwise 
sequence differences and influenced mostly by 
intermediate-frequency variants (Tajima 1989); 
Watterson’s θW, which is based on the number 
of segregating sites and influenced mostly by 
low-frequency variations, theoretically equal 
to the neutral mutation parameter 4Nem 
(Watterson 1975); and θH (Fay and Wu 2000), 
a summary that gives more weight to high fre-
quency–derived alleles. To test whether the fre-
quency spectrum of polymorphisms conformed 
to the standard neutral model, we calculated the 
values of four test statistics: Tajima’s D, which 
considers the difference between π and θW 
(Tajima 1989); Fu and Li’s F* and D*, which 
compare the number of singletons with the 
number of non  singletons (Fu and Li 1993); and 
Fay and Wu’s H, which compared the high-
frequency with intermediate frequency–derived 
variants (Fay and Wu 2000). Significant values 
for these test statistics were estimated from 104 
coalescent simulations of a Wright-Fisher equi-
librium model that conditioned on a constant 
sample size and the level of polymorphism as 
the observed data (Kaplan et al. 1991). We 
also performed the Hudson–Kreitman–Aguade 
(HKA) test to compare the diversity patterns in 
the sequences observed in our study and those 
observed in DMD intron 44 (Nachman and 
Crowell 2000). All neutrality tests and coales-
cent simulations were performed using DnaSP 
software, version 4.0 (Rozas et al. 2003).
Figure 1. Genomic structure of genes and pseudogenes at the CYP3A locus. Abbreviations: Cen, centro­
mere; Qtel, telomere. Exons for genes and pseudogenes are shown as boxes; arrows indicate transcrip­
tional orientation; and broken lines indicate resequenced regions. 
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Table 1. Nucleotide diversity and neutrality tests for the entire CYP3A locus.
Summary statistic Chinese Caucasians Africans Non-Africans Overall
Sample size 29 24 24 48 77
No. of segregating sites 57 60 113 91 167
No. of singletons  32 29 42 42 74
π (× 10–4) 1.6 1.4 4.0 1.5 2.6
θW (× 10–4) 2.8 3.1 5.8 3.9 6.8
θH (× 10–4) 3.5 4.5 5.6 5.1 6.8
D%a  0.97 0.95 0.97 0.95 0.94
Tajima’s D –1.47* –1.96* –1.084 –1.98* –1.99*
Fu and Li’s D* –3.20* –2.21 –1.344 –4.55* –11.10*
Fu and Li’s F* –3.04* –2.52* –1.397 –3.97* –8.48*
Fay and Wu’s H –6.94 –13.81* –5.42 –15.61 –16.24
HKA p-value 0.01** 0.01** 0.01** 0.01** 0.01**
aFixed sequence differences between human and chimpanzee. *p < 0.05. **p < 0.01.Positive selection at CYP3A locus
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We calculated an unbiased small- 
sample estimator of pairwise populations FST 
(F-statistic/fixation index), a measure of allele 
frequency difference among populations and 
an estimate of interpopulation genetic differ-
entiation, as described previously (Weir and 
Cockerham 1984). A bootstrapping method 
(1,000 bootstrap samples) was used to test the 
statistical significance of FST in each pairwise 
comparison between populations. Lewontin’s 
D´ and r2 were applied to evaluate the pairwise 
linkage disequilibrium (LD) between biallelic 
polymorphisms. We used Fisher’s exact test to 
determine the statistical significance of pairwise 
LD, followed by false discovery rate correc-
tion for multiple testing. We used GOLD soft-
ware (Center for Statistical Genetics 2009) as 
described by Abecasis and Cookson 2000) to 
draw the LD maps. 
Haplotypes were constructed using the 
Phase 2.0 program (Stephens and Donnelly 
2003). We then partitioned haplotype blocks 
with HaploBlockFinder (Zhang 2004) as 
described by Zhang and Jin (2003). The 
mutational relation  ships among haplotypes in 
CYP3A43 and CYP3A5 were shown by con-
structing minimum-spanning trees (MSTs), 
with the common chimpanzee as an out-
group species. We calculated the networks 
by reduced median algorithm for CYP3A5 
and median jointing algorithm for CYP3A43 
implicated in the Network 4.1 package 
(Fluxus Technology 2008) as described by 
Bandelt et al. (1999). 
Results
Data summary and sequence variations. 
We sampled 77 unrelated human individu-
als, including 24 Africans, 24 Europeans, and 
29 Asians. The surveyed sequences spanned 
43,675 kb and contained almost all of the 
coding sequences of CYP3A4, CYP3A5, 
CYP3A7, and CYP3A43. We observed a total 
of 167 segregating sites (including 165 bial-
lelic SNPs and two biallelic indel poly-
morphisms) in the human DNA samples 
[see Supplemental Material, Table 1, avail-
able online (doi:10.1289/ehp.0800528.S1 via 
http://dx.doi.org/)], yielding an average density 
of one SNP per 262 bp. Of the variants identi-
fied, 11 were non  synonymous, 2 resulted in a 
splicing defect, 1 was a frame shift mutation, 
and 8 were synonymous.
Sequence divergence between human and 
chimpanzee was 0.95–0.97% for the total 
locus in sub  populations, which was compa-
rable with the genome-wide average of 1.24% 
(Ebersberger et al. 2002). Nucleotide diver-
sity was low in both Chinese and Caucasians: 
1.6 × 10–4 and 1.4 × 10–4, respectively, for 
π; 2.8 × 10–4 and 3.1 × 10–4, respectively, 
for θW (Table 1). When the FST for three-
way population comparisons were estimated 
with polymorphisms site-by-site, 11 FST values 
(ranging from 0.30 to 0.50) fell into the upper 
0.05 tail of the empirical genomewide distri-
butions estimated previously (Bowcock et al. 
1991, Storz et al. 2004) [see Supplemental 
Material, Table 1 (doi:10.1289/ehp.0800528.
S1)]. Comparison of FST for Africans and 
non-Africans using the empirical genome-
  wide FST distribution constructed with similar 
sets of pooled non-African and African sam-
ples (Fullerton et al. 2002) showed that esti-
mated FST values for five variants (T147767C, 
G164751T, T165611C, A169228G, and 
A260167G) were extremely high (≥ 0.40; data 
not shown) and fell above the 95th percentile 
of the empirical distribution.
Selective neutrality tests. Frequency spec-
tra of the derived alleles for the three popu-
lations are shown in Figure 2. Notably, we 
observed an excess of singletons and nearly 
fixed SNPs (derived allelic frequencies 
> 80%). Consistently, Tajima’s D, and Fu 
and Li’s F* and D* deviated significantly from 
Figure 2. Frequency spectrum of derived alleles at the CYP3A locus in Chinese, Caucasians, and Africans. 
The expected frequency spectrum has been reported by Watterson (1975); at the neutral equilibrium, the 
expected number of SNP sites at which the derived allele is present i times in the sample is given by 4Nv/i, 
where N and v are the effective population size and mutation rate, respectively. The formula to estimate 
4Nv is the number of observed segregating sites divided by (1 + 1/2 + 1/3 + . . . + 1/n–1), where n is the 
number of chromosomes in each population. 
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expectations under neutrality in all three popu-
lations examined. When individual popu-
lations were considered, D and F* values in 
both Chinese and Caucasians were significant 
(p < 0.05), and D* was significant in Chinese 
(p < 0.05). We also observed a statistically sig-
nificant H value in Caucasians (p = 0.046). 
Results of the HKA test indicated that the 
nucleotide diversity patterns in the entire sur-
veyed sequences were significantly different 
from those in the neutral DMD intron 44 in 
all three subpopulations (p < 0.05). 
We performed sliding-window analyses 
for the neutrality tests, with each window 
containing 20 variations and with a step size 
of one variation. The values of the neutral-
ity statistics varied widely across the locus in 
all three populations and in sub  populations 
(Figure 3). We observed significantly negative 
D, D*, F*, and H values simultaneously in 
two regions in all the three populations. The 
first region covered the 40.5-kb sequence from 
the CYP3A43–CYP3A4 interval to CYP3A4 
intron 6, or between SNPs C122872T and 
T163355G. The second region covered the 
25.7-kb sequence from the CYP3A5P2–
CYP3A7 interval to CYP3A7 exon 7, or 
between SNPs G191479A and A217213G. 
In addition, significantly negative values for 
all four test statistics were also observed in the 
region from CYP3A43 intron 10 to CYP3A43 
5´-flank region (between SNPs A73018G and 
G106490T) in Chinese, and in the region 
from CYP3A5 exon 2 to CYP3A5 3´ untrans-
lated region (between SNPs C256880T and 
C284792T) in Caucasians. 
Linkage disequilibrium. When 24 SNPs 
shared by all three subpopulations were con-
sidered, mean pairwise |D´| values were sig-
nificantly higher in Chinese (p = 0.001) 
and Caucasians (p < 0.001) compared with 
Africans: values were 0.93, 0.86, and 0.74, 
respectively. The Africans had far fewer SNP 
pairs with r2 ≥ 0.5 compared with either 
Chinese or Caucasians (6.5%, 25.0%, and 
22.8%, respectively). Five SNPs in CYP3A43 
(G83269C, C83448T, A83566G, C83448T, 
and T88726C) were in complete LD with 
each other in all three populations. These five 
SNPs were also in significant LD with both 
the nonsynonymous substitution CYP3A43*3 
and the frame shift mutation CYP3A43*2A 
in non-Africans. The patterns of LD structure 
in each population (Figure 4), delineated with 
polymorphisms with minor allelic frequency 
> 5% in individual populations, also showed 
remarkable differences in extent and strength 
of LD across the entire locus between Africans 
and non-Africans. When the threshold of |D´| 
value was set at 0.8, we observed five, four, 
and seven LD blocks in Chinese, Caucasians, 
and Africans, respectively. The longest blocks 
spanned 60.5 kb in Chinese (block D), 
81.7 kb in Caucasians (block B), and 49.3 kb 
in Africans (block D) (Figure 4).
Haplotype distribution. Because all four 
neutrality tests indicated that nucleo  tide 
diversity patterns in the regions between SNPs 
A73018G and G106490T in CYP3A43 and 
between SNPs C256880T and C284792T in 
CYP3A5 deviated significantly from expected 
under neutrality in non-Africans, we con-
structed the haplotypes in these regions of 
CYP3A43 and CYP3A5 and depicted their 
mutational relationships by constructing 
MSTs rooted with the chimpanzee [Figure 5; 
see also Supplemental Material, Figure 1 
(doi:10.1289/ehp.0800528.S1)]. The haplo-
type MSTs showed two clusters of haplo  types 
for both regions, one main cluster dominated 
with only one common haplotype (Figure 5B, 
left) and one minor cluster scattered with 
haplotypes with low or intermediate frequen-
cies (Figure 5B, right). The haplotype clus-
ters at the CYP3A43 locus were separated by 
five nucleotides at positions 83269, 83448, 
83566, 83643, and 88726, with high fre-
quency–derived alleles at positions 83448 and 
83643 (Figure 5B). The haplotype clusters at 
the CYP3A5 locus were separated by two high 
frequency–derived alleles at positions 260167 
and 284792 [see Supplemental Material, 
Figure 1 (doi:10.1289/ehp.0800528.S1)]. The 
haplotype diversity test showed that haplotype 
diversity in the CYP3A43 region deviated 
obviously from that expected under neutrality 
in Chinese and Caucasians or non-Africans, 
and haplotype diversity in CYP3A5 deviated 
significantly from that expected under neu-
trality in Caucasians (Table 2). 
Discussion and Conclusion
Several lines of evidence indicate signatures 
of natural selection on CYP3A4 and CYP3A7 
in all three populations in our study. First 
of all, we observed extremely low nucle-
otide diversities at both gene loci in all three 
populations. The π values were obviously 
Figure 3. Sliding­window neutrality tests of CYP3A locus. Each window contains 20 variations, with a step 
size of one variation. The midpoint variations at the 20th, 40th, 60th, 80th, 100th, 120th, 140th, and 160th sites 
are T88726C, T116513G, C147742T, A169228G, G186731A, A211137T, T251839A, and T270403C, respectively 
(as shown in Table 1). Circles indicate significant values for corresponding neutrality tests. 
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much lower than the genome-wide average 
for autosomes (7.7 × 10–4), across chromo-
some 7 (7.6 × 10–4) (Stephens et al. 2001), 
and in coding regions for autosomal genes 
(3.4 × 10–4) (Sachidanandam et al. 2001). 
Second, significantly negative values for all 
four statistics (Tajima’s D, Fu and Li’s D* and 
F*, and Fay and Wu’s H) were observed in 
CYP3A4 and CYP3A7. Third, the HKA test 
also indicated a local reduction in variabil-
ity relative to divergence at the CYP3A locus 
compared with the neutral DMD intron 44 
(Nachman and Crowell 2000). 
In agreement with our findings, Qiu 
et al. (2008) also detected particularly strong 
recent positive selections on protein-coding 
sequences of human CYP3A4 and CYP3A7 
after the split of the chimpanzee and human 
lineages or early in hominoid evolution. In 
a recent phylo  genetic investigation, Zawaira 
et al. (2008) also showed that the Gotoh’s sub-
strate recognition sites of human CYP3A is 
associated with the sites under adaptive evolu-
tion. CYP3A is involved in the metabolism of 
foreign compounds, such as naturally occur-
ring flavonoids, diterpenoids in germander, 
pyrrolizidine alkaloids (e.g., echimidine and 
jacobine), and herbal constituents (Zhou et al. 
2007). CYP3A also normally metabolizes food-
derived activators of pregnane X receptor and/
or constitutive androstane receptor, thereby 
regulating the expression of a range of detoxi-
fying systems in the liver (van Waterschoot 
et al. 2009). Therefore, molecular adaptation 
to the evolving environment is possible for the 
CYP3A locus or individual genes in this locus. 
In the present study, we observed that the 
40.5-kb region from the CYP3A4 5´-flanking 
region to CYP3A4 intron 6 was under a recent 
positive selection in human samples over-
all. Thompson et al. (2004) also observed an 
excess of rare variants, as well as a low number 
of polymorphisms, in the CYP3A4 gene in 
non-Africans but not Africans. Schirmer et al. 
(2006) observed that the region centromeric of 
the ancestral CYP3A4*1B allele (which is cor-
related with moderately increased expression 
of CYP3A4 mRNA and protein and increased 
activity) exhibits “high haplotype homozygosity 
in European Caucasians as oppose  d to African 
Americans.” The slight difference between 
our study and that of Thompson et al. (2004) 
may be due to differences in data analysis, as 
all the neutrality tests were performed on the 
assumption of absence of genetic recombina-
tion across the locus. However, recombination 
at the CYP3A locus is possible, as indicated by 
LD structure in the present study. Neutrality 
tests that take recombination into account, 
such as the sliding-window analysis, may be 
more appropriate. Of course, it is still diffi-
cult to pinpoint the evolutionary driving force 
shaping the nucleotide diversity pattern of 
CYP3A4 in our study. In spite of its role in 
the metabolism of xeno  biotics, CYP3A4 also 
metabolizes endogenous chemicals such as the 
eicosanoid metabo  lite endo  cannabinoid anan-
damide (Snider et al. 2007) and uro  porphyrin 
(Franklin et al. 2000); factors that lead to fluc-
tuation of these chemicals might be one of 
selective forces for human CYP3A4.
CYP3A7 shows distinctly high catalytic 
activities for the 16α-hydroxylation of ste-
roids with a C17-keto group, such as estrone 
(Lee et al. 2003) and dehydro  epi  androsterone 
(Ohmori et al. 1998), and plays a role in estriol 
synthesis (Siiteri and MacDonald 1963) and 
retinoic acid metabolism (Marill et al. 2002). 
Leeder et al. (2005) observed extremely low 
expression of CYP3A7 in livers of anencepha-
lic human fetuses. This iso  enzyme is supposed 
to be feto  protective in humans. In the present 
study, we observed that a non  synonymous 
substitution of CYP3A7, N192S, was driven 
to near fixation in all human samples and fixed 
in non-Africans. The N192S SNP occurs in a 
region close to the CYP3As substrate recog-
nition site 2 (Xue et al. 2001). Alignments 
of amino acid sequences with all human 
CYP3A and the orthologs in rat (Cyp3a9) 
Figure 4. LD structures at the CYP3A locus in Chinese (A), Caucasians (B), and Africans (C) as indicated 
by pairwise LD between variations, with minor allele frequency > 5%, measured by |D’|. Haplotype blocks 
partitioned in each population are also shown to the right of corresponding LD structures. 
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and mouse (Cyp3a13) by us indicated that 
the residue 192N is highly conserved (data not 
shown). It is possible that the N192S substitu-
tion affects the regio  selectivity of CYP3A7 
toward its substrates and thus is favored by 
natural selection. Interestingly, Rodríguez-
Antona et al. (2005) recently reported that a 
common non  synonymous variant CYP3A7*2 
is in strong LD with CYP3A5*1. The 
CYP3A7*1/CYP3A5*3 haplotype is associ-
ated with CYP3A7.1 expression but without 
CYP3A5 expression, whereas the CYP3A7*2/
CYP3A5*1 haplotype is associated with the 
expression of CYP3A5 and a more active form 
of CYP3A7 (Rodríguez-Antona et al. 2005). 
Unfortunately, however, we failed to identify 
the CYP3A7*2 variant in our study because 
of the highly homologous sequences of the 
CYP3A family, which prevented our address-
ing the possibility that CYP3A7*2 might be 
the target of positive selection.
One of the novel findings in our study 
was the unique natural selection pattern on 
CYP3A43 in non-Africans. Most CYP3A43 
haplotypes in non-Africans contained the high 
frequency–derived alleles at G83448A and 
C83643T polymorphic sites. In addition, the 
CYP3A43*2 and CYP3A43*3 variants were 
also in significant LD with these SNPs in 
non-Africans. The skewed haplotype structure 
and significant result of haplotype diversity 
test suggest that the major haplotype in this 
region is favored by natural selection in non-
Africans. The five variants that separated the 
two CYP3A43 haplotype clusters had extremely 
high FST values for the Chinese–African and 
Caucasian–African comparisons, which also 
indicates the impact of population-specific 
selective pressures on CYP3A43 in populations 
outside of Africa.
All neutrality tests showed significant 
departure from neutrality for the sequences 
from the CYP3A5 exon 2 to the CYP3A5 
3´ untranslated region in Caucasians. The 
remarkable inter  population differences in both 
frequency spectrum and haplotype structure in 
CYP3A5 also indicate a recent selective sweep 
in Caucasians, which is in accordance with the 
findings by Thompson et al. (2004). CYP3A5 
is important in the metabolism of endogenous 
substrates such as cortisol and in environmen-
tal chemicals such as aflatoxin B1. CYP3A5*3 
reportedly undergoes strong selective pressure 
(e.g., salt sensitivity) (Thompson et al. 2004). 
Other selective pressures, especially from 
dietary chemical exposure, may also play a role 
in shaping the unusual nucleotide diversity 
patterns in CYP3A5 in Caucasians.
It has become clear that populations and 
individuals have their own individual finger-
print of unique allelic architecture coding the 
xeno  biotic response system, and these genetic 
variants have functional relevance with respect 
to drug response and environmentally related 
diseases (Nebert and Dieter 2000). Drug-
metabolizing enzyme (DME) genes are among 
the most favorable targets of natural selection 
for their role in metabolism of environ  mental 
compounds. Recent genome-wide analyses 
indicate that the human xeno  biotic metabo-
lism and disposition system may have under-
gone unique natural selection (Sabeti et al. 
2007). It has also been shown in candidate 
gene–based studies that positive selection 
has acted on DME genes such as CYP1A2 
(Wooding et al. 2002), CYP3A4 and CYP3A5 
(Schirmer et al. 2006; Thompson et al. 
2004), and FMO3 (flavin-containing mono-
oxygenase 3) (Allerston et al. 2007), all phase I 
DME genes; NAT2 (N-acetyltransferase 2) 
Figure 5. Haplotype in the region between SNPs A73018G and G106490T in CYP3A43 and MST of the 
haplotypes. (A) Haplotypes and their estimated frequencies in each population, including the ancestral 
haplotype in chimpanzee (Chimp). (B) MST of the haplotypes in this region: one main cluster with only one 
common haplotype (left) and one minor cluster containing haplotypes of low or intermediate frequency 
(right). The size of each node is proportional to haplotype frequency in all three populations, and the 
frequency of each haplotype within each subpopulation is indicated by various shades within each node. 
Branches represent one nucleotide substitution, unless noted in parentheses. 
Chinese
Caucasians
Africans
Table 2. Haplotype diversity test in CYP3A43 and CYP3A5 gene regions.
CYP3A43  CYP3A5
Population Haplotype diversity p-Value Haplotype diversity p-Value
Chinese 0.257 0.002 0.547 0.226
Caucasian 0.373 0.008 0.467 0.038
African 0.860 0.531 0.801 0.663
Non-African 0.310 0.004 0.518 0.055
Overall 0.533 0.006 0.662 0.076Positive selection at CYP3A locus
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(Patin et al. 2006) and UGT2B17 (UDP-
glucuronosyltransferase 2 family, poly  peptide 
B17) (Xue et al. 2008), both phase II DME 
genes; ABCB1 [ATP-binding cassette, subfam-
ily B, member 1; also named multi  drug resis-
tance 1 (MDR1)] (Tang et al. 2004; Wang 
et al. 2007), and ABCC1 (Wang et al. 2005), 
both phase III DMEs. Among these genes, 
CYP3A and ABCB1 are very interesting outli-
ers because of their unique genetic and bio-
chemical properties. The CYP3A gene cluster 
is located at chromosome 7, just 119 kb away 
from the ABCB1 locus, which codes MDR1 
(P-glycoprotein), the best-characterized 
phase III drug transporter and one of the 
major determinants of the absorption, dis-
tribution, metabolism, and excretion/toxico-
logic profiles for a large range of hydro  phobic 
exogenous substrates, including nearly every 
category of clinically important drugs, with a 
substrate spectrum similar to that of CYP3A 
enzymes. In the liver, lung, kidney, and intes-
tine, there is a close correlation between the 
expressions of CYP3A4 and ABCB1 and their 
transcriptional factor, the pregnane X recep-
tor (Miki et al. 2005), which coordinately 
regulates xenobiotic/drug metabolism and 
efflux through trans-activating the expression 
of the two genes (Synold et al. 2001). We and 
other groups have previously reported positive 
selection on functional derived variants of 
ABCB1 in its coding and regulatory regions 
in human populations, which are correlated 
with increased expression and enhanced 
transporter activity (Tang et al. 2004; Wang 
et al. 2007). The selection hotspot on the 
two closely linked major xeno  biotic response 
genes, CYP3A and ABCB1, superimposed 
with their closely linked genomic map, their 
finely coordinated trans-activation for xeno-
biotic disposition and clearance, and their 
overlapping tissue expression profile and sub-
strate spectrum, may provide a good model 
in evolutionary environmental medicine to 
decipher the integral and dynamic profile of 
the organization, function, and evolution of 
the xeno  biotic disposition system.
In summary, this evolutionary population 
genetics study on the human CYP3A locus 
confirmed the previously reported positive 
selection on CYP3A5 in non-Africans, revealed 
that CYP3A4 and CYP3A7 are under a recent 
or ongoing positive natural selection in the 
general human population, and also pointed 
to positive natural selection on CYP3A43 in 
non-Africans. The complex pattern of natural 
selection on the allelic structure of the CYP3A 
locus may underlie the pheno  typic variation 
in CYP3A activity in populations from dif-
ferent geographic regions and having inter-
ethnic differences in response to drugs and 
herbal medicine as well as ethnic differences in 
predisposition to complex disorders resulting 
from CYP3A-substrate exposure. 
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